Sandu Pharmaceuticals Limited

SANDUPHQ6

INE751D01014

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:51 2024-05-29 am EDT			5-day change	1st Jan Change
58.47 ^INR	-1.32%		-4.74%	-14.14%

Mar. 30	Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	CI
Mar. 30	Sandu Pharmaceuticals Limited Announces Executive Changes	CI

Sandu Pharmaceuticals Limited Approves Appointment of K Vinay Kumar as Chairman

February 14, 2022 at 08:25 am EST

Sandu Pharmaceuticals Limited at its board meeting held on Feb. 14, 2022 approved appointment of Shri K Vinay Kumar, Independent Director(DIN: 02322747) as Chairman of the Company.

Latest news about Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	Mar. 30	CI
Sandu Pharmaceuticals Limited Announces Executive Changes	Mar. 30	CI
Sandu Pharmaceuticals Board Mulls CFO Appointment	Mar. 20	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Sandu Pharmaceuticals CFO to Step Down in December	Nov. 22	MT
Sandu Pharmaceuticals Limited Announces CFO Changes	Nov. 22	CI
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2	Nov. 14	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 13	CI
Sandu Pharmaceuticals Limited Approves Change in Directorate	23-09-30	CI
Sandu Pharmaceuticals Shuts Goa, India Plant for Renovation	23-09-17	MT
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-06	CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023	23-08-14	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-14	CI
Sandu Pharmaceuticals Expands Partnership with Vietnam's Bach Ma Van Xuan; Shares Jump 3%	22-12-12	MT
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals	22-12-10	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	22-10-01	CI
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022	22-08-12	CI
Sandu Pharmaceuticals Forms New Subsidiary for Phytoceuticals Products	22-07-27	MT
Sandu Pharmaceuticals Limited Incorporates Subsidiary	22-07-27	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	22-05-30	CI
Sandu Pharmaceuticals Plans New Phytoceutical Product Subsidiary	22-02-14	MT
Sandu Pharmaceuticals Limited Announces Formation of A Wholly Owned Subsidiary Company	22-02-14	CI
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-14	CI
Sandu Pharmaceuticals Limited Approves Appointment of K Vinay Kumar as Chairman	22-02-14	CI

Chart Sandu Pharmaceuticals Limited

Duration

Period

More charts

Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SANDU PHARMACEUTICALS LIMITED	-14.14%	6.88M
DONG-E-E-JIAO CO.,LTD.	+39.50%	6.23B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.32%	3.32B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.39%	2.91B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-6.41%	2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.43%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-14.15%	1.59B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.27%	1.58B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+38.37%	1.49B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-15.57%	1.48B